• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Quantification and mechanisms of oleic acid-induced steatosis in HepG2 cells.油酸诱导HepG2细胞脂肪变性的定量分析及机制
Am J Transl Res. 2010 Jan 1;2(1):95-104.
2
Quercetin ameliorate insulin resistance and up-regulates cellular antioxidants during oleic acid induced hepatic steatosis in HepG2 cells.栎精通过增加细胞抗氧化剂改善油酸诱导的 HepG2 细胞脂肪变性中的胰岛素抵抗。
Toxicol In Vitro. 2013 Mar;27(2):945-53. doi: 10.1016/j.tiv.2013.01.014. Epub 2013 Jan 21.
3
Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.虾青素和安卡黄素作为天然 AMPK 激活剂,具有 PPARα 激动剂活性,可下调高脂饮食喂养的 C57BL/6 小鼠的非酒精性脂肪性肝炎。
Food Chem Toxicol. 2014 Feb;64:94-103. doi: 10.1016/j.fct.2013.11.015. Epub 2013 Nov 22.
4
[Effect of metformin on mitochondrial pathway of apoptosis and oxidative stress in cell model of nonalcoholic fatty liver disease].二甲双胍对非酒精性脂肪性肝病细胞模型凋亡线粒体途径及氧化应激的影响
Zhonghua Gan Zang Bing Za Zhi. 2020 Jan 20;28(1):64-68. doi: 10.3760/cma.j.issn.1007-3418.2020.01.015.
5
Liv.52 up-regulates cellular antioxidants and increase glucose uptake to circumvent oleic acid induced hepatic steatosis in HepG2 cells.利加隆通过上调细胞抗氧化剂和增加葡萄糖摄取来避免油酸诱导的 HepG2 细胞脂肪变性。
Phytomedicine. 2012 Oct 15;19(13):1156-65. doi: 10.1016/j.phymed.2012.08.005. Epub 2012 Aug 30.
6
The beneficial effects of resveratrol on steatosis and mitochondrial oxidative stress in HepG2 cells.白藜芦醇对HepG2细胞脂肪变性和线粒体氧化应激的有益作用。
Can J Physiol Pharmacol. 2017 Dec;95(12):1442-1453. doi: 10.1139/cjpp-2016-0561. Epub 2017 Jul 31.
7
Low simvastatin concentrations reduce oleic acid-induced steatosis in HepG cells: An model of non-alcoholic fatty liver disease.低辛伐他汀浓度可减轻油酸诱导的HepG细胞脂肪变性:非酒精性脂肪性肝病的一种模型
Exp Ther Med. 2016 Apr;11(4):1487-1492. doi: 10.3892/etm.2016.3069. Epub 2016 Feb 10.
8
The effects of herbal composition Gambigyeongsinhwan (4) on hepatic steatosis and inflammation in Otsuka Long-Evans Tokushima fatty rats and HepG2 cells.草药组合物甘比京辛焕(4)对大冢长-伊原德岛肥胖大鼠和HepG2细胞肝脂肪变性及炎症的影响。
J Ethnopharmacol. 2017 Jan 4;195:204-213. doi: 10.1016/j.jep.2016.11.020. Epub 2016 Nov 11.
9
Oleic acid activates peroxisome proliferator-activated receptor δ to compensate insulin resistance in steatotic cells.油酸通过激活过氧化物酶体增殖物激活受体 δ 来补偿脂肪变性细胞的胰岛素抵抗。
J Nutr Biochem. 2012 Oct;23(10):1264-70. doi: 10.1016/j.jnutbio.2011.07.006. Epub 2011 Dec 29.
10
Lycopus lucidus Turcz. ex Benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice.荆条提取物减轻 HepG2 细胞游离脂肪酸诱导的脂肪变性和高脂饮食诱导肥胖小鼠的非酒精性脂肪肝。
Phytomedicine. 2019 Mar 1;55:14-22. doi: 10.1016/j.phymed.2018.07.008. Epub 2018 Jul 18.

引用本文的文献

1
EGCG and Taurine Synergistically Ameliorate Lipid Metabolism Disorder by Modulating Gut Microbiota and PPARα/FAS Signaling Pathway.表没食子儿茶素没食子酸酯(EGCG)和牛磺酸通过调节肠道微生物群和PPARα/FAS信号通路协同改善脂质代谢紊乱。
Nutrients. 2025 Aug 9;17(16):2595. doi: 10.3390/nu17162595.
2
Induced pluripotent stem cell-derived mesenchymal stem cells for modeling and treating metabolic associated fatty liver disease and metabolic associated steatohepatitis: Challenges and opportunities.诱导多能干细胞衍生的间充质干细胞用于代谢相关脂肪性肝病和代谢相关脂肪性肝炎的建模与治疗:挑战与机遇
World J Stem Cells. 2025 Feb 26;17(2):99331. doi: 10.4252/wjsc.v17.i2.99331.
3
Ethyltoluenes Regulate Inflammatory and Cell Fibrosis Signaling in the Liver Cell Model.乙基甲苯在肝细胞模型中调节炎症和细胞纤维化信号传导。
Toxics. 2024 Nov 27;12(12):856. doi: 10.3390/toxics12120856.
4
Subcellular expression of CYP2E1 in HepG2 cells impacts response to free oleic and palmitic acid.CYP2E1在HepG2细胞中的亚细胞表达影响对游离油酸和棕榈酸的反应。
Curr Res Toxicol. 2024 Sep 28;7:100195. doi: 10.1016/j.crtox.2024.100195. eCollection 2024.
5
Hepatoprotective Effect of Mycelium Powder on Alcohol-Induced Liver Damage.菌丝体粉对酒精性肝损伤的保护作用。
Nutrients. 2024 Oct 8;16(19):3406. doi: 10.3390/nu16193406.
6
Ezetimibe, Niemann-Pick C1 like 1 inhibitor, modulates hepatic phospholipid metabolism to alleviate fat accumulation.依折麦布,一种尼曼-匹克C1样蛋白1抑制剂,可调节肝脏磷脂代谢以减轻脂肪堆积。
Front Pharmacol. 2024 Jun 17;15:1406493. doi: 10.3389/fphar.2024.1406493. eCollection 2024.
7
Nesfatin-1 and nesfatin-1-like peptide attenuate hepatocyte lipid accumulation and nucleobindin-1 disruption modulates lipid metabolic pathways.内脂素-1 和内脂素-1 样肽可减轻肝细胞脂质蓄积,核结合蛋白-1 破坏可调节脂质代谢途径。
Commun Biol. 2024 May 27;7(1):623. doi: 10.1038/s42003-024-06314-2.
8
Hydroalcoholic extract from (Jacq.) S.w. root reverses oleic acid-induced steatosis and insulin resistance .(Jacq.)S.w.根的水醇提取物可逆转油酸诱导的脂肪变性和胰岛素抵抗。
Heliyon. 2024 Jan 17;10(2):e24567. doi: 10.1016/j.heliyon.2024.e24567. eCollection 2024 Jan 30.
9
Effects of riboflavin deficiency and high dietary fat on hepatic lipid accumulation: a synergetic action in the development of non-alcoholic fatty liver disease.核黄素缺乏与高膳食脂肪对肝脏脂质积累的影响:在非酒精性脂肪性肝病发展中的协同作用
Nutr Metab (Lond). 2024 Jan 2;21(1):1. doi: 10.1186/s12986-023-00775-8.
10
Enhancement of Growth and Secondary Metabolites by the Combined Treatment of Trace Elements and Hydrogen Water in Wheat Sprouts.微量元素和氢气水联合处理对小麦芽生长和次生代谢物的促进作用。
Int J Mol Sci. 2023 Nov 25;24(23):16742. doi: 10.3390/ijms242316742.

本文引用的文献

1
Development of an in vitro cell culture model of hepatic steatosis using hepatocyte-derived reporter cells.利用肝细胞衍生的报告细胞建立肝脂肪变性的体外细胞培养模型。
Biotechnol Bioeng. 2009 Apr 1;102(5):1466-74. doi: 10.1002/bit.22191.
2
Mechanisms of disease progression in nonalcoholic fatty liver disease.非酒精性脂肪性肝病的疾病进展机制
Semin Liver Dis. 2008 Nov;28(4):370-9. doi: 10.1055/s-0028-1091981. Epub 2008 Oct 27.
3
Role of peroxisome proliferators-activated receptors in the pathogenesis and treatment of nonalcoholic fatty liver disease.过氧化物酶体增殖物激活受体在非酒精性脂肪性肝病发病机制及治疗中的作用
World J Gastroenterol. 2008 Jan 7;14(1):22-8. doi: 10.3748/wjg.14.22.
4
PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty-acid metabolic enzymes.过氧化物酶体增殖物激活受体激动剂治疗通过调节脂肪酸代谢酶,在非酒精性脂肪性肝病动物模型中有效。
J Gastroenterol Hepatol. 2008 Jan;23(1):102-9. doi: 10.1111/j.1440-1746.2006.04819.x.
5
The dual peroxisome proliferator-activated receptor alpha/gamma agonist tesaglitazar further improves the lipid profile in dyslipidemic subjects treated with atorvastatin.双重过氧化物酶体增殖物激活受体α/γ激动剂替格列扎进一步改善了接受阿托伐他汀治疗的血脂异常患者的血脂状况。
Metabolism. 2007 Sep;56(9):1285-92. doi: 10.1016/j.metabol.2007.05.003.
6
A Three Stage Integrative Pathway Search (TIPS) framework to identify toxicity relevant genes and pathways.
BMC Bioinformatics. 2007 Jun 14;8:202. doi: 10.1186/1471-2105-8-202.
7
Microarray analyses and molecular profiling of steatosis induction in immortalized human hepatocytes.永生化人肝细胞脂肪变性诱导的微阵列分析和分子谱分析
Lab Invest. 2007 Aug;87(8):792-806. doi: 10.1038/labinvest.3700590. Epub 2007 Jun 11.
8
Pathogenesis of non-alcoholic steatohepatitis: human data.非酒精性脂肪性肝炎的发病机制:人类数据。
Clin Liver Dis. 2007 Feb;11(1):75-104, ix. doi: 10.1016/j.cld.2007.02.011.
9
Pathogenesis of NASH: animal models.非酒精性脂肪性肝炎的发病机制:动物模型
Clin Liver Dis. 2007 Feb;11(1):55-74, viii. doi: 10.1016/j.cld.2007.02.010.
10
A human hepatocellular in vitro model to investigate steatosis.一种用于研究脂肪变性的人肝细胞体外模型。
Chem Biol Interact. 2007 Jan 30;165(2):106-16. doi: 10.1016/j.cbi.2006.11.004. Epub 2006 Nov 23.

油酸诱导HepG2细胞脂肪变性的定量分析及机制

Quantification and mechanisms of oleic acid-induced steatosis in HepG2 cells.

作者信息

Cui Wei, Chen Stephen L, Hu Ke-Qin

机构信息

Division of Gastroenterology and Hepatology, Dept. of Medicine, University of California Irvine, CA, USA.

出版信息

Am J Transl Res. 2010 Jan 1;2(1):95-104.

PMID:20182586
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2826826/
Abstract

Developing a quantifiable in vitro model of steatosis is critical in understanding the pathogenesis of nonalcoholic fatty liver disease (NAFLD) and searchingfor effective therapies. Using an ORO-based colorimetric measurement, we developed a convenient assay to qualify the degree of OA-induced steatosis in HepG2 cells. We demonstrated that in the absence of exogenous inflammatory mediators, OA-induced steatosis was associated with increased production and secretion of tumor necrosis factor alpha and decreased expression of peroxisome proliferators-activated receptor alpha in HepG2 cells. OA-induced steatosis was also associated with increased lipid peroxidation, apoptosis, but decreased proliferation in these cells. The increased lipid peroxidation was related to decreased SOD-1, a free radical scavenger enzyme; while increased apoptosis was related to increased active caspase-9. The decreased proliferation mediated by OA-induced steatosis was associated with increased production of p27 with unchanged alanine transaminase (ALT) level in the culture medium, indicating OA-induced steatosis alters cell cycle progression without direct toxicity to these cells. In conclusion, the present study developed a colorimetric assay that accurately quantifies OA-induced steatosis in HepG2 cells. In the absence of exogenous inflammatory mediators, OA-induced steatosis results in a series of pathophysilogical changes in HepG2 cells, indicating direct pathogenic roles of hepatocytes in NAFLD.

摘要

建立可量化的脂肪变性体外模型对于理解非酒精性脂肪性肝病(NAFLD)的发病机制和寻找有效治疗方法至关重要。我们利用基于油红O的比色法测量,开发了一种简便的检测方法来鉴定油酸(OA)诱导的HepG2细胞脂肪变性程度。我们证明,在没有外源性炎症介质的情况下,OA诱导的脂肪变性与HepG2细胞中肿瘤坏死因子α的产生和分泌增加以及过氧化物酶体增殖物激活受体α的表达降低有关。OA诱导的脂肪变性还与这些细胞中脂质过氧化增加、细胞凋亡增加但增殖减少有关。脂质过氧化增加与自由基清除酶超氧化物歧化酶1(SOD-1)减少有关;而细胞凋亡增加与活性半胱天冬酶-9增加有关。OA诱导的脂肪变性介导的增殖减少与p27产生增加有关,而培养基中丙氨酸转氨酶(ALT)水平不变,这表明OA诱导的脂肪变性改变细胞周期进程,而对这些细胞无直接毒性。总之,本研究开发了一种比色法检测,可准确量化OA诱导的HepG2细胞脂肪变性。在没有外源性炎症介质的情况下,OA诱导的脂肪变性导致HepG2细胞发生一系列病理生理变化,表明肝细胞在NAFLD中具有直接致病作用。